Inventory, Net of ACCENDRA HEALTH INC/VA/ from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Summary
ACCENDRA HEALTH INC/VA/ quarterly Inventory, Net in USD history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • ACCENDRA HEALTH INC/VA/ Inventory, Net for the quarter ending 30 Sep 2025 was $63,847,000, a 95% decline year-over-year.
Source SEC data
View on sec.gov
Inventory, Net, Quarterly (USD)
Inventory, Net, YoY Quarterly Change (%)

ACCENDRA HEALTH INC/VA/ Quarterly Inventory, Net (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $63,847,000 -$1,178,606,000 -95% 30 Sep 2025 10-Q 31 Oct 2025 2025 Q3
Q2 2025 $69,227,000 -$1,162,186,000 -94% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $1,408,539,000 +$263,942,000 +23% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $67,581,000 -$1,043,025,000 -94% 31 Dec 2024 10-Q 31 Oct 2025 2025 Q3
Q3 2024 $1,242,453,000 +$158,103,000 +15% 30 Sep 2024 10-Q 04 Nov 2024 2024 Q3
Q2 2024 $1,231,413,000 +$63,186,000 +5.4% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 $1,144,597,000 -$143,691,000 -11% 31 Mar 2024 10-Q 03 May 2024 2024 Q1
Q4 2023 $1,110,606,000 -$222,979,000 -17% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 $1,084,350,000 -$424,093,000 -28% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $1,168,227,000 -$357,104,000 -23% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $1,288,288,000 -$159,095,000 -11% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $1,333,585,000 -$162,387,000 -11% 31 Dec 2022 10-K 20 Feb 2024 2023 FY
Q3 2022 $1,508,443,000 -$5,944,000 -0.39% 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 $1,525,331,000 -$5,036,000 -0.33% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 $1,447,383,000 +$124,486,000 +9.4% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $1,495,972,000 +$262,221,000 +21% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $1,514,387,000 +$418,977,000 +38% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $1,530,367,000 +$489,506,000 +47% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 $1,322,897,000 +$214,053,000 +19% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 $1,233,751,000 +$87,559,000 +7.6% 31 Dec 2020 10-K 23 Feb 2022 2021 FY
Q3 2020 $1,095,410,000 -$57,669,000 -5% 30 Sep 2020 10-Q 03 Nov 2020 2020 Q3
Q2 2020 $1,040,861,000 -$196,852,000 -16% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $1,108,844,000 -$101,714,000 -8.4% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $1,146,192,000 -$127,534,000 -10% 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q3 2019 $1,153,079,000 -$50,759,000 -4.2% 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $1,237,713,000 +$17,598,000 +1.4% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $1,210,558,000 +$188,847,000 +18% 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 $1,273,726,000 +$283,533,000 +29% 31 Dec 2018 10-K 04 Mar 2020 2019 FY
Q3 2018 $1,203,838,000 +$214,587,000 +22% 30 Sep 2018 10-Q 05 Nov 2018 2018 Q3
Q2 2018 $1,220,115,000 +$216,039,000 +22% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 $1,021,711,000 +$72,365,000 +7.6% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 $990,193,000 +$73,882,000 +8.1% 31 Dec 2017 10-K 06 Mar 2019 2018 FY
Q3 2017 $989,251,000 +$44,354,000 +4.7% 30 Sep 2017 10-Q 02 Nov 2017 2017 Q3
Q2 2017 $1,004,076,000 +$46,104,000 +4.8% 30 Jun 2017 10-Q 02 Aug 2017 2017 Q2
Q1 2017 $949,346,000 +$23,632,000 +2.6% 31 Mar 2017 10-Q 03 May 2017 2017 Q1
Q4 2016 $916,311,000 -$24,464,000 -2.6% 31 Dec 2016 10-K 23 Feb 2018 2017 FY
Q3 2016 $944,897,000 +$48,175,000 +5.4% 30 Sep 2016 10-Q 02 Nov 2016 2016 Q3
Q2 2016 $957,972,000 +$54,471,000 +6% 30 Jun 2016 10-Q 03 Aug 2016 2016 Q2
Q1 2016 $925,714,000 +$50,976,000 +5.8% 31 Mar 2016 10-Q 04 May 2016 2016 Q1
Q4 2015 $940,775,000 +$68,318,000 +7.8% 31 Dec 2015 10-K 17 Feb 2017 2016 FY
Q3 2015 $896,722,000 +$62,246,000 +7.5% 30 Sep 2015 10-Q 28 Oct 2015 2015 Q3
Q2 2015 $903,501,000 +$82,619,000 +10% 30 Jun 2015 10-Q 28 Jul 2015 2015 Q2
Q1 2015 $874,738,000 +$106,590,000 +14% 31 Mar 2015 10-Q 28 Apr 2015 2015 Q1
Q4 2014 $872,457,000 +$100,794,000 +13% 31 Dec 2014 10-K 25 Feb 2016 2015 FY
Q3 2014 $834,476,000 +$46,673,000 +5.9% 30 Sep 2014 10-Q 29 Oct 2014 2014 Q3
Q2 2014 $820,882,000 +$26,862,000 +3.4% 30 Jun 2014 10-Q 30 Jul 2014 2014 Q2
Q1 2014 $768,148,000 +$24,901,000 +3.4% 31 Mar 2014 10-Q 01 May 2014 2014 Q1
Q4 2013 $771,663,000 +$7,907,000 +1% 31 Dec 2013 10-K 23 Feb 2015 2014 FY
Q3 2013 $787,803,000 +$10,905,000 +1.4% 30 Sep 2013 10-Q 07 Nov 2013 2013 Q3
Q2 2013 $794,020,000 +$45,173,000 +6% 30 Jun 2013 10-Q 02 Aug 2013 2013 Q2
Q1 2013 $743,247,000 +$19,041,000 +2.6% 31 Mar 2013 10-Q 03 May 2013 2013 Q1
Q4 2012 $763,756,000 -$42,610,000 -5.3% 31 Dec 2012 10-K 25 Feb 2014 2013 FY
Q3 2012 $776,898,000 +$15,906,000 +2.1% 30 Sep 2012 10-Q 02 Nov 2012 2012 Q3
Q2 2012 $748,847,000 -$2,766,000 -0.37% 30 Jun 2012 10-Q 27 Jul 2012 2012 Q2
Q1 2012 $724,206,000 -$5,340,000 -0.73% 31 Mar 2012 10-Q 27 Apr 2012 2012 Q1
Q4 2011 $806,366,000 +$86,250,000 +12% 31 Dec 2011 10-K 22 Feb 2013 2012 FY
Q3 2011 $760,992,000 +$27,696,000 +3.8% 30 Sep 2011 10-Q 28 Oct 2011 2011 Q3
Q2 2011 $751,613,000 +$39,535,000 +5.6% 30 Jun 2011 10-Q 29 Jul 2011 2011 Q2
Q1 2011 $729,546,000 31 Mar 2011 10-Q 29 Apr 2011 2011 Q1
Q4 2010 $720,116,000 31 Dec 2010 10-K 24 Feb 2012 2011 FY
Q3 2010 $733,296,000 30 Sep 2010 10-Q 29 Oct 2010 2010 Q3
Q2 2010 $712,078,000 30 Jun 2010 10-Q 30 Jul 2010 2010 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.